Archives
-
Neurotensin: An Assay Design Framework
2026-08-25
Neurotensin is a Neurotensin receptor 1 activator suited to mechanistic studies of GPCR trafficking and miRNA responses. This guide connects endpoint selection, peptide handling, and spectral quality control.
-
Removing Pollen Interference in EEM Bioaerosol Detection
2026-08-25
Zhang et al. developed a fluorescence-data workflow that combines spectral preprocessing, feature transformation, and random forest classification to reduce pollen interference in hazardous bioaerosol identification. Fast Fourier transform processing improved the reported classification performance to 89.24%, helping distinguish pathogens and toxins in complex excitation–emission matrix datasets.
-
scaRNA1 Editing Links U2 Ψ89 to Splicing
2026-08-24
Gardner-Kay et al. used CRISPR-Cas9 disruption of scaRNA1 in HEK293T cells to connect reduced pseudouridylation at U2 Ψ89 with broad transcript isoform changes. The study provides a useful causal framework for studying how guide-RNA-dependent modification of spliceosomal RNA can influence RNA processing, while its cell-line design limits direct extrapolation to developmental disease models.
-
EZ Cap™ Cy5 EGFP mRNA: Assay Logic
2026-08-24
EZ Cap™ Cy5 EGFP mRNA (5-moUTP) enables researchers to separate nanoparticle uptake from functional translation in advanced gene-delivery studies. This article presents a practical assay framework for interpreting dual-fluorescence data, informed by recent β-cell-targeted lipid nanoparticle research.
-
Western Secondary Antibody Dilution Buffer Workflow
2026-08-23
Build cleaner, more reproducible Western blots for NHE1, Olfr2, and inflammatory signaling studies with a stabilized secondary-antibody workflow. The approach combines controlled dilution, practical reuse, and mechanism-aware troubleshooting to improve assay efficiency without overinterpreting immunoblot data.
-
Liver sEH–Nrf2 Control of Osteoclastogenesis
2026-08-22
A 2025 study identifies a liver–bone axis in which hepatic soluble epoxide hydrolase alters circulating epoxide metabolites and inflammatory signals, thereby suppressing Nrf2-ARE activity in bone and promoting osteoclast differentiation. Its integrated clinical, animal, cellular, and transcriptomic design provides a mechanistic framework for studying redox imbalance in osteoporosis and related enzyme inhibition studies.
-
Dual-Action p38α Inhibitors and Dephosphorylation
2026-08-22
A 2024 bioRxiv preprint shows that selected kinase inhibitors can do more than occupy the p38α catalytic site: they can also accelerate activation-loop dephosphorylation by WIP1. Structural and biochemical evidence supports a mechanism in which inhibitor-stabilized loop conformations expose phospho-threonine, suggesting a route to more durable and target-selective kinase inhibition.
-
Gemcitabine Workflows for DNA Damage Research
2026-08-21
Gemcitabine provides a practical benchmark for connecting replication stress with checkpoint activation, cell-cycle arrest, and apoptosis. This workflow combines dose-ranging, orthogonal phenotyping, and transcriptomics-informed assay design for cancer research, including osteosarcoma models.
-
Linoleic Acid–PPARα–TF Signaling in pLELC
2026-08-20
This reference study integrates serum proteomics, untargeted metabolomics, functional testing, and a patient-derived xenograft model to investigate primary pulmonary lymphoepithelioma-like carcinoma. It proposes a linoleic acid–PPARα–tissue factor axis that reshapes immune-cell infiltration and promotes tumor progression, positioning tissue factor as a candidate therapeutic target while highlighting the context dependence of PPARα signaling.
-
Aprotinin Workflows for Protease-Controlled Assays
2026-08-20
Aprotinin enables reversible control of trypsin, plasmin, and kallikrein in blood, cell, and inflammation research workflows. This guide connects fibrinolysis inhibition and cardiovascular surgery blood management models with membrane-biophysics assay design, while emphasizing formulation controls and troubleshooting.
-
Pyridostatin TFA in G-Quadruplex Research
2026-08-19
Pyridostatin TFA provides a practical way to stabilize G-quadruplexes while connecting telomere biology research with emerging studies of nucleic-acid-regulated protein condensation. This workflow-focused guide covers dose design, assay controls, comparative applications, and troubleshooting for cancer and neurodegeneration-oriented experiments.
-
Streptozotocin: Designing Causal Diabetes Models
2026-08-19
Streptozotocin enables controlled experimental diabetes mellitus induction through selective pancreatic β-cell cytotoxicity. This guide moves beyond model generation to show how STZ can support rigorous causal studies of diabetic neuropathy, inflammation, and therapeutic response.
-
Methicillin Sodium Salt for MSSA Research
2026-08-18
Build reproducible MSSA susceptibility, cell-wall stress, and infection-model workflows with Methicillin sodium salt. This guide distinguishes actionable MSSA benchmarking from MRSA resistance analysis and provides practical setup, optimization, and troubleshooting strategies.
-
Ribonuclease R (RNase R) (20 U/μL) Guide
2026-08-18
Learn how Ribonuclease R (RNase R) (20 U/μL), SKU K3061, can strengthen circular RNA validation before interpreting cell proliferation, viability, or cytotoxicity phenotypes. This scenario-driven guide covers experimental controls, protocol calculations, data interpretation, and practical product-selection criteria.
-
TRIM21, ERK1/2, and Drug Resistance in Pituitary Adenomas
2026-08-17
The reference study identifies TRIM21 as a regulator of pituitary adenoma proliferation and dopamine-agonist resistance through K27-linked ubiquitination and phosphorylation of ERK1/2. Its combination of CRISPR screening, proteomics, interaction assays, animal studies, and NanoBiT drug screening positions TRIM21 as a mechanistically testable therapeutic target and highlights Quisinostat as a candidate for reducing resistance-associated signaling.